Spyre Therapeutics Correlations

SYRE Stock   27.75  0.08  0.29%   
The current 90-days correlation between Spyre Therapeutics and Milestone Pharmaceuticals is 0.35 (i.e., Weak diversification). The correlation of Spyre Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Spyre Therapeutics Correlation With Market

Very weak diversification

The correlation between Spyre Therapeutics and DJI is 0.49 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spyre Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Spyre Stock refer to our How to Trade Spyre Stock guide.

Moving together with Spyre Stock

  0.66LPTX Leap TherapeuticsPairCorr
  0.61PHVS Pharvaris BVPairCorr
  0.76PLRX Pliant TherapeuticsPairCorr
  0.77PMVP Pmv PharmaceuticalsPairCorr
  0.63SGMO Sangamo Therapeutics Buyout TrendPairCorr
  0.63CRVS Corvus PharmaceuticalsPairCorr

Moving against Spyre Stock

  0.46FDMT 4D Molecular TherapeuticsPairCorr
  0.44MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.4MNOV MediciNovaPairCorr
  0.33NKTX Nkarta Inc Buyout TrendPairCorr
  0.4ACIU AC ImmunePairCorr
  0.38BDTX Black Diamond TherapPairCorr
  0.35ADAP Adaptimmune TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SCPHELYM
TPSTELYM
MCRBELYM
SCPHTPST
MISTRNXT
MCRBSCPH
  
High negative correlations   
LUMOTPST
LUMOELYM
LUMOMCRB
LUMOSCPH
MISTSCPH
MISTELYM

Risk-Adjusted Indicators

There is a big difference between Spyre Stock performing well and Spyre Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spyre Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Spyre Therapeutics Corporate Management

James JDConsultantProfile
Janet MBASenior OperationsProfile
Eric McIntyreVice RelationsProfile
Deanna MDSenior DevelopmentProfile
CFE CPAVice ControllerProfile
Justin LaFountaineSenior DevelopmentProfile